These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6028086)

  • 21. [Mixed, Yoshida-type tumors, resistant and sensitive to alkylating agents].
    Winkler A; Ujházy V; Sándor L; Drahovský D
    Cas Lek Cesk; 1966 Sep; 105(39):1068-71. PubMed ID: 5976461
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of compounds on a spectrum of rat tumors.
    Sugiura K; Schmid FA; Schmid MM; Brown GF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):231-308. PubMed ID: 4350013
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of DBM on rat ascites tumors and antibody production.
    Irikura T; Kawasaki H; Enta R; Hasegawa Y
    Chem Pharm Bull (Tokyo); 1970 Feb; 18(2):394-6. PubMed ID: 4314621
    [No Abstract]   [Full Text] [Related]  

  • 24. [Application of tumor cell culture--screening of antineoplastic drugs].
    Sakurai Y
    Gan No Rinsho; 1967 Feb; 13(2):84-9. PubMed ID: 6070925
    [No Abstract]   [Full Text] [Related]  

  • 25. The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth inhibition and cell size in sensitive and resistant strains of the Yoshida ascites sarcoma.
    Harrap KR; Hill BT
    Br J Cancer; 1969 Mar; 23(1):227-34. PubMed ID: 5768439
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study about the growth of two tumors of the solid Yoshida sarcoma of the rat in the same animals as well as about the reactions of tumors of different sizes to treatment with 2-, 3-, 5-trisethyleneiminobenzochinone (1,4) (author's transl)].
    Hartleib J
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974 Mar; 81(1):1-6. PubMed ID: 4275054
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of the nuclear reactivity of alkylating agents by prednisolone.
    Wilkinson R; Birbeck MS; Harrap KR
    Cancer Res; 1979 Oct; 39(10):4256-62. PubMed ID: 476658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy.
    Harrap KR; Hill BT
    Br J Cancer; 1969 Mar; 23(1):210-26. PubMed ID: 5768437
    [No Abstract]   [Full Text] [Related]  

  • 30. Carcinostatic combined therapy as viewed from its invasive effect on tumor cells.
    Takayama T; Konishi K; Hayasaka H; Nozaki S
    Int Surg; 1967 Aug; 48(2):180-8. PubMed ID: 6058195
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro-in vivo studies on the susceptibility of the solid Yoshida sarcoma to drugs and hyperthermia (42 degrees).
    Dickson JA; Suzangar M
    Cancer Res; 1974 Jun; 34(6):1263-74. PubMed ID: 4363651
    [No Abstract]   [Full Text] [Related]  

  • 32. [Strain of Yoshida sarcoma with induced pafencil resistance].
    Khomchenovskiĭ EI; Burova GF
    Biull Eksp Biol Med; 1985 Apr; 99(4):479-81. PubMed ID: 3986376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the problem of the effectiveness of d-glyceraldehyde].
    Brock N; Niekamp T
    Z Krebsforsch; 1965 Jul; 67(1):93-104. PubMed ID: 4221137
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correlation of the differences of biological effects and distribution parameters of 1,6-dibromohexitols].
    Institóris L; Dzurillay E; Sebestyén JH; Jeney A; Pethes G
    Z Krebsforsch; 1971; 75(2):133-45. PubMed ID: 4256522
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. I].
    Venuti A; Fimiani V; Gioffre' MA; Micali B
    Chir Patol Sper; 1982 Aug; 29(4):161-6. PubMed ID: 7172845
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. II].
    Venuti A; Gioffre' MA; Micali B; Caputo G
    Chir Patol Sper; 1982 Aug; 29(4):167-71. PubMed ID: 7172846
    [No Abstract]   [Full Text] [Related]  

  • 38. [Synthesis and tumor inhibiting effect of N-(bis(2-chlorethyl)-aminomethyl)-amides. 21. Cytostatic agents].
    Schönenberger H; Bindl L; Adam A
    Arch Pharm (Weinheim); 1973 Jan; 306(1):64-75. PubMed ID: 4691046
    [No Abstract]   [Full Text] [Related]  

  • 39. [ON THE EFFECT OF GLUCOSE ON THE TOXIC AND THERAPEUTIC EFFECTS OF 1,6-DIBROMO-1,6-D-DIDESOXYMANNITOL IN ANIMAL EXPERIMENTS].
    CSANYI E; HORVATH P; INSTITORIS L
    Neoplasma; 1964; 11():441-50. PubMed ID: 14220333
    [No Abstract]   [Full Text] [Related]  

  • 40. A new antitumour agent: phenazathionium-mustard salt.
    Csaba G; Körösi J
    Neoplasma; 1968; 15(4):443-5. PubMed ID: 5684468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.